Location History:
- Guangdong, CN (2007)
- Shenzhen, CN (2009)
Company Filing History:
Years Active: 2007-2009
Title: Aihua Xie: Innovator in Histone Deacetylase Inhibitors
Introduction
Aihua Xie is a notable inventor based in Shenzhen, China, recognized for his significant contributions to the field of pharmaceutical sciences. With a total of two patents, Xie's research has a profound impact on the treatment of cell proliferative diseases, including cancer and psoriasis.
Latest Patents
Xie's latest patents feature innovative benzamide derivatives that act as histone deacetylase inhibitors (HDACIs). The primary invention is centered around the preparation and pharmaceutical use of these novel compounds, which are defined in the specification of formula (I). These derivatives demonstrate potent differentiation and anti-proliferation activity, providing new avenues for treating various diseases related to cell proliferation.
Career Highlights
Aihua Xie is associated with Shenzhen Chipscreen Biosciences, Ltd., where he engages in cutting-edge research and the development of therapeutic solutions. His work at this prominent research institution highlights his commitment to advancing medical science through innovative inventions.
Collaborations
Throughout his career, Xie has collaborated with notable colleagues, including Xian-Ping Lu and Zhibin Li. These partnerships enrich his research endeavors and enable the synthesis of ideas that foster innovative solutions in the pharmaceutical landscape.
Conclusion
Aihua Xie's contributions to the development of histone deacetylase inhibitors underscore his role as a pivotal figure in the field of pharmaceutical research. His innovative spirit and collaborative efforts continue to pave the way for advancements in treating serious health conditions, making a lasting impact on the industry.